Valeant to sell Obagi skin-care business for US$190M

LAVAL, Que. – Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash. The Quebec-based company, headquartered in Laval, estimates its Obagi Medical …
( read original story …)